Tetra Bio-Pharma Gets CA$4.5M From Québec's Government To Develop Medicine For ARDS
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1) announced the approval of a CA$4.5 million ($3.53 million) participative loan from the ministère de l'Économie et de l'Innovation (MEI) under the BioMed Propulsion Program, managed by Investissement Québec (IQ)</
